Media
Displaying 31 - 40 of 59
Santen and NTC announce positive outcome of European Decentralised Procedure (DCP) for Ducressa®, a broad spectrum, 7-day post-cataract surgery antibiotic/steroid combination treatment
As a healthcare company that is well represented across the globe. Santen’s mission is to contribute to the well-being of patients, their loved ones and consequently to society.
Santen and jCyte conclude an exclusive licensing agreement for jCell, a cell therapy for retinitis pigmentosa
As the COVID-19 pandemic continues to impact families, communities and businesses, healthcare systems are re-configuring to address the challenge.
On Wednesday 22 April 2020, over 700 EMEA colleagues and 40 guests from our headquarters in Japan, joined Santen’s first ever Virtual Conference.
As a healthcare company that is well represented across the globe, Santen’s mission is to contribute to the well-being of patients, their loved ones and consequently to society.
Santen EMEA held its European Ocular Surface Summit on Friday 6 March as a one-day virtual meeting for 45 ophthalmologists from across Europe.
As a healthcare company that is well represented across the globe, Santen’s mission is to contribute to the well-being of patients, their loved ones and consequently to society.
Santen presents surgical offering at ICGS 2020
Santen and Verily establish joint venture to develop and commercialise unique ophthalmic devices
